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The present study was designed to evaluate the biological potential of Cuscuta reflexa and Carthamus oxyacantha.
The ethanolic crude extract (C. reflexa; 9.1% and C. oxyacantha; 10.4%) was partitioned with different solvents at pH
3.0, 9.0 and 7.0. Phytochemical study showed that n-hexane fractions were rich source of terpenoids and ethyl
acetate fractions were phenolic in nature while chloroform fractions contained alkaloidal skeleton. Total phenols
were calculated with FC method and ranged 3.5 to 71.4 mg GAE/100 g DW. Antioxidant (DPPH & FRAP), enzyme
inhibition potential (Protease & AChE) and antimicrobial activities were examined by the standard protocols. It was
observed that about all extracts exhibited significant DPPH activity range (IC50 09 ± 0.5 to 62 ± 1.2 μg/ml). The DPPH
active extracts/fractions also showed remarkable reducing potential. A strong correlation has been found between
phenolics and antioxidant activities. Antimicrobial assay that was performed against four microbes and results revealed
that FMC-6 and FMP-8 were active against all the tested microbes, while FMP-2 was inactive. Eight extracts/fractions of
these plants expressed more than 50% inhibition of the targeted enzymes.
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The nature’s garden of medicine is being exposed since
ancient civilization era. Still more than three fourth (3/4)
of the world population depends on medicinal plants or
their extracts for life sustaining process. As these are
capable to assuage and treat human ailments and infirm-
ity. The metabolites particularly the secondary one (ter-
penoids, alkaloids, saponins, flavonoids, steroids etc.)
that are produced by plants are responsible for the
therapeutic outcomes. The remedial plants have exten-
sive application in food industry pharmaceutical, agricul-
tural and cosmetics (Bukhsh et al. 2007; Fellows 1991;
Fransworth and Moris 1976; Ahmad et al. 2006).
Cuscuta reflexa Roxb. belongs to family Cuscutaceae
alternate Convolvulaceae commonly known as akasbail
or amarwala. It is found in Pakistan, India, China, east-
ern Asia and Afghanistan C. reflexa is used as constitu-
ent of many medical compositions, which are effective in
the treatment of headache, itching, migraine, chronic ca-
tarrh, amnesia, epilepsy, expectorates, prolong fever and
constipation. It has been examined as anticonvulsant,* Correspondence: asamgcu@yahoo.com
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in any medium, provided the original work is pmuscle relaxant, antioxidant, antihypertensive, cardio-
tonic, antiviral, and antibacterial. Many phytochems like
cuscutine, stigmasterol, kaempferol, dulcitol, myricetin
and coumarin have been isolated from C. reflexa (Sharma
et al. 2012; Manish et al. 2012; Anis et al. 2002).
Carthamus oxyacantha belongs to family Asteraceae
found in Pakistan, Afghanistan, India, Iran, Azerbaijan,
Iraq and Kyrgyzstan. It is a winter season plant that grows
up in the wheat fields (Zadeh et al. 2011; Meshram et al.
2011). C. oxyacantha is used for wound healing and anti-
inflammatory purposes. It has potential for antimicrobial,
antioxidant and antiworm actions. Young leaves of C. oxy-
acantha are utilized as a vegetable, while seeds are used in
cooking and it is an alternative for true saffron as a natural
food colorant. Two types of oils are produced by this spe-
cie: oleic oil and linoleic oil. Two major pigments are
found in its flowers: carthamidin and the carthamin. Seeds
and flowers have compounds like glycosides, serotonin,
flavonoids, and sterols (Souri et al. 2004; Hassan et al.
2010).
Free radicals are the chemical species which contains
unpaired electrons. These unpaired electrons make these
species very reactive due to which they cause oxidativeOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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dative stress is involved in the pathogenesis of many ail-
ments, like Parkinson’s and Alzheimer’s disease. It can
damage lipids, carbohydrates, proteins, and DNA in the
cells (Ratnam et al. 2006). Antioxidants stand for a
prime line of protection in opposition to the reactive
oxygen species and free radicals. Plants hold a group of
phenolic compounds that have the potential to scavenge
free radicals and thus act as natural antioxidants. Herbal
medicines that have antioxidant potential are being
used worldwide for the treatment of various diseases.
Medicinal plants are being focused for the extraction of
natural antioxidants that can replace synthetic additives
because of the toxicological risks associated with syn-
thetic antioxidants (El-Haci et al. 2013; Drummen et al.
2004).
Infectious diseases are one of the principal reasons be-
hind the early deaths throughout the world, killing al-
most 50,000 people each day. So a great deal of
attention is being paid to drugs, resistance to human
pathogenic bacteria. The drugs that can restrain the
growth of pathogens or may eradicate them are called
antibiotics and these must possess minimum lethality to
the host cells. Traditionally a lot of remedial plants are
being used for the healing of different infectious diseases
because they generate a wide range of compounds that
are known for therapeutic activities. e.g. penicillin (Perez
et al. 1990; Kalayou et al. 2012).
Enzymes are the biological catalyst that accelerates the
specific biochemical reactions and this specificity is very
essential for life to sustain. The factors which affect en-
zyme activity are enzyme concentration, the amount of
specific enzyme substrate, pH of the medium for enzyme
activity, the presence of activators and the presence of
inhibitors. If any of these factors is not suitable for a par-
ticular reaction the activity of enzyme may change. This
may lead to low or over activity of enzyme which results
a wide category of ailments such as diabetes, Alzeimer’s
disease, lysosomal storage disorders, human immuno-
deficiency virus (HIV) infection and cancer. The chem-
ical substances which affect the activity of enzymes in a
specific chemical way are called inhibitors. The inhibi-
tors may be naturally occurring like antipepsin and anti-
trypsin or they may be synthetic drugs like temocapril,
sulfa drugs and lisinopril. The application of these drugs
as specific enzyme inhibitors, inhibits the unwanted
metabolic pathways in the body and for that reason
these drugs are named antimetabolites. The synthetic
drugs produce side effects so this research is focused on
the search of natural inhibitors for economic and safety
purposes. The medicinal plant extracts and plant-
derived chemicals can replace this therapeutic approach
for the treatment of a wide category of disorders. For ex-
ample the phenolic compounds, obtained from plantsplay a significant role in mediating amylase inhibition
(Braga et al. 2007; Fan et al. 2010).
During last decades use of herbal medicines is increas-
ing rapidly because of their no side effects, easy access
and low cost. Keeping in view the medicinal importance
of plants, the present study was carried out to assess the
biological activities of these selected plants and qualita-
tive and quantitative estimation of phytochemicals




(FC) reagent, 2,4,6-Tripyridyl-s-triazine (TPTZ), 5,5′-
Dithio-bis-[2-nitrobenzoic acid] (DTNB), Nα-benzoyl-
DL-arginine-paranitroanilide hydrochloride (BApNA),
Proteases, Acetylcholine esterase (AChE), Acetylcholine
iodide (AChI) were purchased from Sigma-Aldrich/Fluka
(Germany). Microbes used in this studies were gifted by
Department of Zoology, University of Gujrat, Gujrat
(Pakistan).
Collection of plant material
Cuscuta reflexa Roxb. was collected from different areas
of the Azad Kashmir while, Carthamus oxyacantha was
collected from District Chakwal (Punjab). The plants
were identified at the Botany Department of University
of Gujrat, Gujrat (Pakistan).
Preparation of plant extracts
The fresh plant material was dried in shade at room
temperature for twenty days then grinded. Extraction of
pulverized plant material (100 grams each) was carried
out by soaking in 5.0 L (ethanol:water; 90:10) for ten
days with shaking at regular interval. The extracts were
filtered with filter paper and then concentrated it at low
temperature and reduced pressure on rotary evaporator
to yield residue (crude extract). Crude extract was dis-
solved in dist. water and after stirring filtered the mater-
ial, then the filtrate was fractioned with n-hexane,
chloroform (pH 3, 9 and 7), ethyl acetate and n-butanol.
Phytochemical studies
Phytochemical studies were carried out with the different
spraying and coloring agents (ferric chloride, n-butanol-
HCl, AlCl3, cerric sulphate, urea-HCl, and dragendorff ’s)
for the detection of the phenolics, triterpenoids, saponins,
alkaloids, flavonoids and sugars (Praveen and Sharmishtha
2012; Williams and Grayer 2004).
Antioxidant activity
DPPH assay
For the estimation of the anti-radical potential, DPPH
radical scavenging activity of all the extracts/fractions
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2010). To 100 μl of the extract (2 mg/ml) added 2 ml of
the DPPH solution (25 mg/l) and kept the mixture for
30 min at room temperature. Methanol was used as a
baseline correction and the absorbance of the fractions/
samples was observed at 517 nm using UV/Vis Spectro-
photometer. Gallic acid was used as standard and the
antioxidant activity of all extracts was expressed as per-
centage inhibition using following formula;
% Inhibition of DPPH ¼ A B
A
 100
Where; A = absorbance of blank and B = absorbance of
the sample
FRAP assay
FRAP assay of extracts/fractions was conceded out by
using the method of Shahwar et al. (2012). The FRAP
reagent consists of 300 mM acetate buffer of pH 3.6, 20
mM solution FeCl3.6H2O and 10 mM 2,4,6-tripyridyl-s-
triazine (TPTZ). 200 μl plant extracts were mixed to
FRAP reagent, allowed to stand for six minutes and ab-
sorbance was noted at 593 nm.
Total phenol
Total phenol contents (TPC) of all the fractions were
assessed by using Folin-Ciocalteu (FC) reagent. (Qureshi
et al. 2011). To 200 μl of each of the sample solution
(2 mg/ml) 100 μl of FC reagent and 200 μl of sodium
bicarbonate solution (10%) were added. Then left the
mixture for 30 min at room temperature and the ab-
sorbance was measured at 765 nm using UV/Vis Spectro-
photometer. Solutions having varying concentrations of
gallic acid were prepared in order to plot a calibration
curve. The amount of total phenolic content of each ex-
tract/fractions was articulated as mg/100 g equivalent to
gallic acid using the above calibration curve.
Antimicrobial activity
Antimicrobial activity of all extracts was evaluated ac-
cording to agar well diffusion method (Shahwar et al.
2009) against four selected microbes (Bacillus species
AQ-1, Bacillus species AQ-2, Bacillus species AZ-1,
Bacillus species AZ-2) isolated from soil. Growth
medium (Nutrient broth and agar-agar: 2 grams each in
100 ml) was prepared and poured in the petri dishes,
cotton dip in the culture medium was swapped on the
surface of solid medium. Four small cavities were made
by using a sterilized micro-pipette tip (6 mm). 60 μl of
extracts (2 mg/ml) were poured out in the hole with the
help of micro-pipette. All the steps involved in the prep-
aration of inoculums and petri dishes were performed in
aseptic medium. Culture plates containing bacteria wereplaced in incubator at 37°C. After 24 hours of incubation
the zone of inhibition (mm) was observed on plates.
Enzyme inhibition activity
Protease inhibition assay
Protease inhibition assay was carried out by using the
method of Shahwar et al. (2011) Tris buffer (100 mM)
of pH 7.5 was prepared by dissolving 12.1 g of Tris
(hydroxymethyl)-aminomethane in distilled water and
adjusted pH 7.5 with HCl (5 M). 2 mg of trypsin
(Sigma-Aldrich) were dissolved in 10 ml of 1.0 mM
HCl in order to prepare the stock solution. Nα-benzoyl-
DL-arginine-paranitroanilide hydrochloride (BApNA) was
dissolved in DMSO (20 mg/ml). Enzyme (50 μl) and 200
μl sample solution (2 mg/ml in DMSO) were incubated at
37°C for 15 minutes. Then added 30 μl of substrate and
the final volume of 2.5 ml was made by adding tris buffer.
Then again incubated the reaction mixture at 37°C for
30 minutes. The absorbance was noted using UV/Vis
spectrophotometer at 410 nm. The percentage inhib-
ition was determined by using the following formula:
% Inhibition ¼ Absorbance blankð Þ  Absorbance testð Þ
Absorbance blankð Þ  100
Acetylcholine esterase inhibition activity
Acetylcholine esterase inhibition activity of plant extract
was evaluated by using the spectrophotometric method
explained by Abbasi et al. (2012). 50 μl of each sample
solution (2 mg/ml in DMSO) was taken in a test tube,
added 50 μl of enzyme and incubated reaction mixture
for 15 min at room temperature. After incubation, added
30 μl of DTNB followed by the 30 μl addition of sub-
strate (AChI). Absorbance was noted at 412 nm using
UV/Vis spectrophotometer.
Results and discussion
Health treatments based on medicinal plants are being
prescribed by doctors in the form of plant extracts, infu-
sion or by direct ingestion of very fine powder of plant.
Likewise these are recommended as a nutritional supple-
ment for the treatment of everyday problems such as
stress and insomnia. There is a resurgence of interest in
herbal medicine for the treatment of various ailments,
chiefly because of the prohibitive cost of allopathic
drugs, their unavailability in remote areas and the popu-
lar belief that naturally occurring products are without
any adverse side-effects.
From a medical point of view, the important constitu-
ents of plants are pharmacologically active compounds
such as flavonoids, alkaloids, glycosides and similar
other organic substances. In addition, medicinal plants
contain essential and trace elements, which can be
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and their extracts. Indeed today many, if not most,
pharmacological classes of drugs include a natural prod-
uct prototype. The search for pharmacologically active
chemicals from plant sources has continued and many
compounds have been isolated and introduced into clin-
ical medicine. Modern medicine is now beginning to
accept the use of standardized plant extracts. Present
study was conducted also to enhance the same know-
ledge further and is focused to investigate chemical com-
position including phytochemical and biological studies
of Cuscuta reflexa Roxb & Carthamus oxyacantha,
Cuscuta reflexa Roxb. and Carthamus oxyacantha.
These were collected from various regions of the Punjab
(Pakistan) on the basis of its medicinal importance from
available data. The fresh plant material was extracted in
aqueous ethanol and then partitioned with different
solvent on polarity basis yielding seven organic soluble
fractions.
All extracts/fractions were subjected to different test
for screening of phytochemical tests which gave indica-
tion of phenolics, triterpenoids and alkaloids compounds
(Table 1).
Total phenolic contents were calculated using FC
methods expressed as gallic acid equivalents and it wasTable 1 Phytochemical studies of selected plants
Plant sample Alkaloids Saponins Triterpenoids Sugars
FMC-1 - - + -
FMC-2 - - + -
FMC-3 +++ - +++ -
FMC-4 ++ - + -
FMC-5 - - + -
FMC-6 - - ++ -
FMC-7 - - - -
FMC-8 - - - -
FMP-1 - - + -
FMP-2 - - + -
FMP-3 - - ++++ -
FMP-4 ++ - +++ -
FMP-5 - - ++ -
FMP-6 - - ++ -
FMP-7 - - - -
FMP-8 - - - -
FMC-1; Crude extract of C. reflexa, FMC-2; n-hexane fraction of C. reflexa, FMC-3;
Chloroform (acidic) fraction of C. reflexa, FMC-4; Chloroform (basic) fraction of C.
reflexa, FMC-5; Choloroform (neutral) fraction of C. reflexa, FMC-6; Ethyl acetate
fraction of C. reflexa, FMC-7; n-butanol fraction of C. reflexa, FMC-8; Water fraction
of C. reflexa, FMP-1; Crude extract of C. oxycantha, FMP-2; n-hexane fraction
of of C. oxycantha, FMP-3; Chloroform (acidic) fraction of C. oxycantha,
FMP-4; Chloroform (basic) fraction of C. oxycantha, FMP-5; Choloroform
(neutral) fraction of C. oxycantha, FMP-6; Ethyl acetate fraction of C. oxycantha,
FMP-7; n-butanol fraction of C. oxycantha,, FMP-8; Water fraction of C. oxycantha
- Not active + Slight active ++ Moderate active +++ Significantly active.concluded that ethanolic, chloroform and ethyl acetate
extracts contained considerable amounts of phenolic
contents (FMC-1:71.4, FMC-6:54.4 & FMP-3:63.7 GAE/
100 g DW). The order of phenolics in extracts for C.
reflexa is FMC-1 > FMC-5 > FMC-7 > FMC-2 > FMC-6 >
FMC-3 > FMC-4 > FMC-8 and similarly for C. oxya-
cantha is; FMP-6 > FMP-3 > FMP-7 > FMP-5 > FMP-1 >
FMP-4 > FMP-8 > FMP-2 as shown in Table 2.
Antioxidant potential of all fractions was monitored
with DPPH and FRAP assay. The DPPH is an organic
free radical which is very stable with ʎmax 517 nm and it
is one of the most commonly used reagents for estima-
tion of antioxidant potential of different compounds.
The change of color from purple to yellow as the free
radical is hunted by the antioxidants causes a decrease
in the absorbance and it was resulted that most of the
fractions showed remarkable activity in both assays
(Ashokkumar et al. 2008; Conforti et al. 2009). Highest
antiradical activity was shown by FMC-7 (94.5%) with
IC50 16 μg as shown in Table 2 while the gallic acid was
used as standard with 94.4% inhibition and IC50 of 4 μg.
The maximum reducing power was exhibited by FMC-
I = 825.9 μM equivalent to FeSO4.7H2O as shown in
Table 3. The findings of the present study revealed that
the extracts were free radical inhibitors and acted as
primary antioxidants.
Antibacterial activity of all extracts and fractions was
done against four soil isolated bacterial strains. FMC-6Table 2 Total phenolic contents and antioxidant activities
of selected plants
Code aTotal phenol DPPH activity cFRAP
b%Inhibition IC50 (μg/ml)
FMC-1 71.4 ± 0.8 92.3 ± 1.8 20 ± 0.6 825.9 ± 21.5
FMC-2 62.2 ± 0.8 93.5 ± 1.0 30 ± 0.7 492.5 ± 10.3
FMC-3 53.5 ± 1.1 92.5 ± 0.9 18 ± 0.5 677.8 ± 11.7
FMC-4 45.0 ± 0.7 93.0 ± 1.5 12 ± 0.6 404.8 ± 9.7
FMC-5 66.4 ± 1.2 93.3 ± 1.0 16 ± 0.3 462.8 ± 10.3
FMC-6 54.4 ± 1.3 90.3 ± 1.2 18 ± 0.4 315.1 ± 7.3
FMC-7 65.5 ± 1.0 94.5 ± 1.5 16 ± 0.5 355.8 ± 9.1
FMC-8 36.1 ± 0.7 82.0 ± 0.9 09 ± 0.5 208.7 ± 1.1
FMP-1 40.1 ± 0.6 91.5 ± 1.4 32 ± 0.8 225.7 ± 2.4
FMP-2 3.5 ± 0.0 25.6 ± 0.5 - 5.9 ± 1.0
FMP-3 63.7 ± 0.6 85.6 ± 1.1 24 ± 0.7 623.6 ± 13.5
FMP-4 34.1 ± 0.8 90.2 ± 1.5 40 ± 1.0 431.2 ± 10.3
FMP-5 45.6 ± 0.9 90.0 ± 1.3 58 ± 1.6 511.5 ± 8.1
FMP-6 67.4 ± 0.8 92.2 ± 1.0 32 ± 1.0 606.5 ± 11.1
FMP-7 54.1 ± 1.1 39.1 ± 0.7 - 421.2 ± 7.9
FMP-8 28.7 ± 0.5 52.6 ± 0.5 62 ± 1.2 270.2 ± 6.9
amg GAE/100 g DW b100 µl (2 mg/ml) c200 µl (2 mg/ml) and expressed in μM
equivalent to FeSO4.7H2O.
Table 3 Enzyme inhibition (%) activity of plant fractions
Sample/Fractions aProtease bAChE
FMC-1 92.73 ± 1.5 85.42 ± 1.0
FMC-2 82.91 ± 1.1 89.17 ± 08
FMC-3 62.00 ± 1.3 50.81 ± 1.1
FMC-4 15.01 ± 0.7 0.00 ± 0.0
FMC-5 9.41 ± 0.5 0.00 ± 0.0
FMC-6 91.42 ± 1.0 85.22 ± 1.7
FMC-7 5.92 ± 0.5 0.00 ± 0.0
FMC-8 90.40 ± 1.0 91.95 ± 1.5
FMP-1 66.04 ± 0.9 59.01 ± 0.9
FMP-2 0.00 ± 0.0 0.00 ± 0.0
FMP-3 88.05 ± 1.7 83.96 ± 1.1
FMP-4 18.52 ± 0.7 11.50 ± 0.6
FMP-5 0.00 ± 0.0 0.00 ± 0.0
FMP-6 14.91 ± 1.0 9.63 ± 1.0
FMP-7 9.41 ± 0.8 0.00 ± 0.0
FMP-8 96.54 ± 0.9 91.09 ± 1.3
a100 μl (2 mg/ml) b50 μl (2 mg/ml).
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tivity against all the selected bacterium while remaining
showed significant activity. It was very interesting that
FMC-6 (31 mm against AZ-2, 26 mm against AZ-1, 26
mm against AQ-2 and 28 mm against AQ-1) exhibited ac-
tivity greater than standards (Streptomycin and Ampici-
line) as shown in Figure 1. Plants can supply a wide range
of valuable constituents for the development of novel che-
motherapeutics. One step towards this objective is the
evaluation of in vitro antibacterial activity of different
plants. Many reports have been presented on the anti-
microbial, anti-inflammatory, antimolluscal and antihel-
mintic potentials of plants. The antibacterial activity has
been ascribed due to the existence of some active constitu-
ents in the plant extracts. The selected plants exhibited aFigure 1 Antimicrobial activities of extracts against selected Bacillus sbroad spectrum of antibacterial activities which may be
useful for the development of new classes of natural and
semi-synthetic antibiotics that might be used to treat a wide
category of infectious diseases (Samy and Ignacimuthu
2000; Shahid et al. 2013). So, it is clear from the findings of
the current study that the plant extracts have great
biological effects. However, there is need to study other
biological studies and advance purifications.
Acetylcholine esterase and trypsin (proteases) inhib-
ition studies of plant extracts were conducted using well
known reported methods and it was concluded that
most of plant extracts showed remarkable enzyme inhib-
ition activity as mentioned in Table 3 particularly by
FMC-8 and trypsin inhibition activity by FMP-8. Scien-
tists are engaged in searching of substitute, effective and
secure therapeutic agents, a major thrust area in the
mainstream of pharmaceutical research. Medicinal
plants play a crucial role for the advancement of new
drugs. Plant materials remain a significant resource to
combat severe diseases in the world. Pharmacognostic
investigations of plants are carried out to find new drugs
or templates for the development of novel bioactive
agents. The use of traditional medicine is expanding glo-
bally and their use not only for primary health care in
developing countries, but also in countries where con-
ventional medicine is predominant in the national health
care system. In vitro pharmacological investigations of
traditionally used medicinal plants offers an incredible
chance to discover and investigate a broad range of
plant-based drugs as a potential source of novel biologic-
ally active agents and to validate claims made on their
safety and efficacy.
Conclusion
Recent years have seen an exponential increase in re-
search of antioxidant properties of plants and it is ac-
cepted that higher intakes of natural antioxidants
containing phenolics are associated with long-termpecies.
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pathogenesis of tissue damage, consequently having im-
plications in many clinical conditions. A lot of research
is being under taken to identify new plant resources
which have no or minimum side effects and potential
antioxidant capacity. So, higher antioxidant potential
showed by these plants may prove helpful to treat many
diseases like aging, cancer and Parkinson’s disease. The
restriction of bacterial growth by the plant extracts in
present study validated the conventional use of plants in
curing of infections due to which millions of people die
each year throughout the world. Bioactive compounds
from these plants can therefore be utilize for the formu-
lation of antimicrobial therapeutics for the treatment of
a variety of bacterial and fungal infectivity including
pneumonia, gonorrhea, mycotic and eye infections.
AChE inhibition activities may prove of novel values in
clinical trials for the treatment of Alzheimer’s disease.
Isolation, identification and purification of these phyto-
chemicals and investigation of their relevant antimicro-
bial antioxidants, enzyme inhibition potentials and
toxicological estimation with the idea of formulating
novel chemotherapeutics should be the future direction
for searching.
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